Citations 2
Efficacy of Mirikizumab in Comparison to Ustekinumab in Patients With Moderate-to-Severe Crohn’s Disease: Results From the Phase 3 VIVID-1 Study
Ferrante, M., Kaser, Arthur , Reinisch, Walter, Bragg, S. M., Lin, Zhantao, Lopes, Michelle Ugolini, Protić, Marijana , Jairath, Vipul , Sands, Bruce E , Bossuyt, Peter , Farraye, Francis A. , Hisamatsu, T., Kierkuś, Jarosław , Laharie, David , Siegmund, Britta , Hon, Kam‐Lun Ellis , Morris, Nathan , Danese, Silvio
Zeitschrift für Gastroenterologie | November 27, 2025 | Volume: 62 | Issue: 05 | Pages: e481-e482
P115 Efficacy of mirikizumab in comparison to ustekinumab in patients with moderate-to-severe Crohn’s disease: results from phase 3 VIVID 1 study
Sands, Bruce E, Ferrante, Marc, Hisamatsu, Tadakazu , Kaser, Arthur , Reinisch, Walter , Bragg, Sonja M., Hon, Emily, Lin, Zhantao, Lopes, Michelle Ugolini, Protić, Marijana , Dhesi, Endip , Jairath, Vipul , Bossuyt, Peter , Farraye, Francis A. , Kierkuś, Jarosław , Laharie, David , Reinisch, Walter , Siegmund, Britta , Morris, Nathan , Danese, Silvio
Poster Presentations | July 1, 2024 | Volume: No volume available | Issue: No issue available | Pages: A120.1-A120